Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ReNAgade Therapeutics
Biotech
Vertex and Orna team up to develop new blood disorder treatments
Vertex is hoping to build out its inherited blood disease portfolio, teaming up with Orna to develop next-gen gene therapies for SCD and TDT.
Gabrielle Masson
Jan 7, 2025 7:00am
MHRA CEO Raine to depart in Autumn —Chutes & Ladders
Mar 1, 2024 9:30am
ReNAgade lays off 10% of staff 6 months after $300M series A
Dec 5, 2023 10:15am
A 'painful reset' for biotech brings small checks, green shoots
Aug 2, 2023 10:29am
Former Arena CEO takes over new RNA biotech—Chutes & Ladders
May 26, 2023 9:30am
New RNA biotech raises $300M in largest private round of 2023
May 23, 2023 6:30am
